Advances in Molecular Pathology reviews the year’s most important findings and updates within the field in order to provide molecular pathologists with the current clinical information they need to improve patient outcomes. A distinguished editorial board, led by Dr. Gregory Tsongalis, identifies key areas of major progress and controversy and invites preeminent specialists to contribute original articles devoted to these topics. These insightful overviews in molecular pathology inform and enhance clinical practice by bringing concepts to a clinical level and exploring their everyday impact on patient care.
Provides in-depth, clinical reviews in molecular pathology, providing actionable insights for clinical practice.
Presents the latest information in the field under the leadership of an experienced editorial team. Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Editorial Board - p. iii 6. Contributors - p. v 7. Editorial - p. xv 8. Preface - p. xvii 9. Genetics - p. xvii 10. Polygenic Risk Scores in Clinical Care - p. 1 11. Hereditary Cancer and Cancer Predisposition Syndromes - p. 9 12. Hematopathology - p. 27 13. Expanding the Molecular Landscape of Cutaneous T-Cell Lymphoma - p. 29 14. High-Grade B-cell Lymphomas - p. 41 15. Molecular Advances in Nodal Peripheral T-Cell Lymphoma - p. 51 16. Multiple Myeloma - p. 59 17. Infectious Disease - p. 71 18. Prevalence and Clinical Disease Severity of Respiratory Coinfections During the Coronavirus Disease 2019 Pandemic - p. 73 19. Applications of Long-Read Sequencing Technology in Clinical Genomics - p. 85 20. Pharmacogenomics - p. 108 21. SLCO1B1 Pharmacogenetics in Pediatrics - p. 109 22. Implementation of a Clinical Pharmacogenomics Service in a Large Freestanding Pediatric Health System - p. 119 23. Artificial Intelligence/Machine Learning and Mechanistic Modeling Approaches as Translational Tools to Advance Personalized Medicine Decisions - p. 131 24. Solid tumors - p. 139 25. Advances in Cell-Free DNA - p. 141
Advances in Molecular Pathology reviews the year’s most important findings and updates within the field in order to provide molecular pathologists with the current clinical information they need to improve patient outcomes. A distinguished editorial board, led by Dr. Gregory Tsongalis, identifies key areas of major progress and controversy and invites preeminent specialists to contribute original articles devoted to these topics. These insightful overviews in molecular pathology inform and enhance clinical practice by bringing concepts to a clinical level and exploring their everyday impact on patient care.
Provides in-depth, clinical reviews in molecular pathology, providing actionable insights for clinical practice.
Presents the latest information in the field under the leadership of an experienced editorial team. Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Editorial Board - p. iii 6. Contributors - p. v 7. Editorial - p. xv 8. Preface - p. xvii 9. Genetics - p. xvii 10. Polygenic Risk Scores in Clinical Care - p. 1 11. Hereditary Cancer and Cancer Predisposition Syndromes - p. 9 12. Hematopathology - p. 27 13. Expanding the Molecular Landscape of Cutaneous T-Cell Lymphoma - p. 29 14. High-Grade B-cell Lymphomas - p. 41 15. Molecular Advances in Nodal Peripheral T-Cell Lymphoma - p. 51 16. Multiple Myeloma - p. 59 17. Infectious Disease - p. 71 18. Prevalence and Clinical Disease Severity of Respiratory Coinfections During the Coronavirus Disease 2019 Pandemic - p. 73 19. Applications of Long-Read Sequencing Technology in Clinical Genomics - p. 85 20. Pharmacogenomics - p. 108 21. SLCO1B1 Pharmacogenetics in Pediatrics - p. 109 22. Implementation of a Clinical Pharmacogenomics Service in a Large Freestanding Pediatric Health System - p. 119 23. Artificial Intelligence/Machine Learning and Mechanistic Modeling Approaches as Translational Tools to Advance Personalized Medicine Decisions - p. 131 24. Solid tumors - p. 139 25. Advances in Cell-Free DNA - p. 141
